351 related articles for article (PubMed ID: 28483691)
1. 3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems.
Brancato V; Gioiella F; Profeta M; Imparato G; Guarnieri D; Urciuolo F; Melone P; Netti PA
Acta Biomater; 2017 Jul; 57():47-58. PubMed ID: 28483691
[TBL] [Abstract][Full Text] [Related]
2. 3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro.
Brancato V; Gioiella F; Imparato G; Guarnieri D; Urciuolo F; Netti PA
Acta Biomater; 2018 Jul; 75():200-212. PubMed ID: 29864516
[TBL] [Abstract][Full Text] [Related]
3. Recapitulating spatiotemporal tumor heterogeneity in vitro through engineered breast cancer microtissues.
Mazio C; Casale C; Imparato G; Urciuolo F; Netti PA
Acta Biomater; 2018 Jun; 73():236-249. PubMed ID: 29679778
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-cleavable nanocapsules for tumor-activated drug release.
Iaccarino G; Profeta M; Vecchione R; Netti PA
Acta Biomater; 2019 Apr; 89():265-278. PubMed ID: 30851453
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer.
Brancato V; Comunanza V; Imparato G; Corà D; Urciuolo F; Noghero A; Bussolino F; Netti PA
Acta Biomater; 2017 Feb; 49():152-166. PubMed ID: 27916739
[TBL] [Abstract][Full Text] [Related]
6. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
Subia B; Dey T; Sharma S; Kundu SC
ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
[TBL] [Abstract][Full Text] [Related]
7. A novel human 3D lung microtissue model for nanoparticle-induced cell-matrix alterations.
Kabadi PK; Rodd AL; Simmons AE; Messier NJ; Hurt RH; Kane AB
Part Fibre Toxicol; 2019 Apr; 16(1):15. PubMed ID: 30943996
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip.
Shin K; Klosterhoff BS; Han B
Mol Pharm; 2016 Jul; 13(7):2214-23. PubMed ID: 27228477
[TBL] [Abstract][Full Text] [Related]
9. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
[TBL] [Abstract][Full Text] [Related]
10. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
12. Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors.
Wang T; Wang D; Liu J; Feng B; Zhou F; Zhang H; Zhou L; Yin Q; Zhang Z; Cao Z; Yu H; Li Y
Nano Lett; 2017 Sep; 17(9):5429-5436. PubMed ID: 28753017
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
[TBL] [Abstract][Full Text] [Related]
14. Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model.
Ozcelikkale A; Shin K; Noe-Kim V; Elzey BD; Dong Z; Zhang JT; Kim K; Kwon IC; Park K; Han B
J Control Release; 2017 Nov; 266():129-139. PubMed ID: 28939108
[TBL] [Abstract][Full Text] [Related]
15. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of In Vitro Cancer Microtissue Array on Fibroblast-Layered Nanofibrous Membrane by Inkjet Printing.
Park TM; Kang D; Jang I; Yun WS; Shim JH; Jeong YH; Kwak JY; Yoon S; Jin S
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112150
[TBL] [Abstract][Full Text] [Related]
17. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
18. Tumor-activated prodrug (TAP)-conjugated nanoparticles with cleavable domains for safe doxorubicin delivery.
Guarnieri D; Biondi M; Yu H; Belli V; Falanga AP; Cantisani M; Galdiero S; Netti PA
Biotechnol Bioeng; 2015 Mar; 112(3):601-11. PubMed ID: 25220931
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
20. 3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues.
Brancato V; Garziano A; Gioiella F; Urciuolo F; Imparato G; Panzetta V; Fusco S; Netti PA
Acta Biomater; 2017 Jan; 47():1-13. PubMed ID: 27721010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
